product line
MISSION®
form
solid
mature sequence
UGGUGCGGAGAGGGCCCACAGUG
Sanger mature/minor accession no.
Sanger microRNA accession no.
storage temp.
−20°C
Gene Information
human ... hsa-miR-675(100126270)
General description
即用型MISSION miRNA模拟物是小的双链RNA分子,旨在模拟导入细胞时的内源性成熟miRNA分子。已知miRNA以多种方式调节基因表达,包括翻译抑制,mRNA裂解和去腺苷酸化。MISSION miRNA模拟物是MISSION RNAi产品家族的成员,为miRNA研究人员提供了一系列选择,从单个MISSION Mimics到基于最新版本miRBase的完整人类miRNA 模拟物库(目前由曼彻斯特大学主办,以前由桑格研究所主办)。
- 优化并准备进行转染。
- 新型MISSION miRNA模拟设计已在功能上测试了针对天然miRNA靶标的敲低效率。
- 独特的MISSION miRNA模拟设计显著降低了可能的有义链脱靶效应。
- 可作为整个人类文库和单个miRNA靶标获得。
Biochem/physiol Actions
The microRNA hsa-miR-675 (also referred to as hsa-miR-675-5p) is present in H19, a long non coding RNA. It is mainly involved in carcinogenesis. This miRNA is downregulated in non-small cell lung cancer (NSCLC) and is associated with tumor progression and development. It works as a tumor suppressor in NSCLC by targeting GPR55 (G-protein coupled receptor 55). The hsa-miR-675 is upregulated in colon cancer and helps in hypoxia-mediated epithelial to mesenchymal transition. It targets ZEB1 (zinc finger E-box-binding homeobox 1) at the post-transcriptional level and controls the progression of pancreatic cancer cells. It also has an oncogenic role in esophageal squamous cell carcinoma by targeting REPS2 (RalBP1-associated Eps domain-containing protein 2).
Other Notes
miRBase V18 Mature ID update: hsa-miR-675-5p
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
相关内容
The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis.
Wang J
Oncotarget, 8, 24978-24987 (2017)
Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D
Molecular Cancer, 14 (2015)
H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C
Oncotarget, 6, 29209-29223 (2015)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| HMI0903-5NMOL | 04061831384291 |